Cargando…

Early Identification of Progressive TB Disease Using Host Biomarkers

Detalles Bibliográficos
Autores principales:	Rachow, Andrea, Heinrich, Norbert, Geldmacher, Christof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484510/ https://www.ncbi.nlm.nih.gov/pubmed/26137551 http://dx.doi.org/10.1016/j.ebiom.2015.01.009

Ejemplares similares

Effect of TB Treatment on Neutrophil-Derived Soluble Inflammatory Mediators in TB Patients with and without HIV Coinfection
por: Sitoe, Nádia, et al.
Publicado: (2023)

Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and Posttreatment
por: Nwongbouwoh Muefong, Caleb, et al.
Publicado: (2021)

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol
por: Rachow, Andrea, et al.
Publicado: (2019)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

Use of host lipids by the Lyme disease spirochete may lead to biomarkers
por: Arora, Gunjan, et al.
Publicado: (2022)

The TAM-TB Assay—A Promising TB Immune-Diagnostic Test With a Potential for Treatment Monitoring
por: Ahmed, Mohamed I. M., et al.
Publicado: (2019)

Back to the future, again: greater leadership, collaboration and accountability to accelerate progress to end TB
por: Weil, Diana, et al.
Publicado: (2018)

Biomarkers of HIV Susceptibility and Disease Progression()
por: Pirrone, Vanessa, et al.
Publicado: (2014)

Identification and validation of host biomarkers for leprosy: A step forward to establish point-of-care tests
por: Nausch, Norman, et al.
Publicado: (2019)

TB Transmission: Closing the Gaps
por: Comas, Iñaki, et al.
Publicado: (2018)

Where are the RNA vaccines for TB?
por: Fan, Xiao-Yong, et al.
Publicado: (2021)

A world of cities and the end of TB
por: Prasad, Amit, et al.
Publicado: (2016)

Integrated testing for TB and COVID-19
por: MacLean, Emily L., et al.
Publicado: (2022)

Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-γ and Granzyme B and inter- individual variation
por: Mensah, Gloria Ivy, et al.
Publicado: (2014)

Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study
por: Marambire, Edson Tawanda, et al.
Publicado: (2022)

A Paradigm to Discover Biomarkers Associated With Chronic Kidney Disease Progression
por: Ali, Ibrahim, et al.
Publicado: (2020)

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
por: Hafkin, Jeffrey, et al.
Publicado: (2017)

Monitoring CD27 Expression to Evaluate Mycobacterium Tuberculosis Activity in HIV-1 Infected Individuals In Vivo
por: Schuetz, Alexandra, et al.
Publicado: (2011)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

bTB eradication in Ireland: where to from here?
por: More, Simon J.
Publicado: (2023)

Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold
por: Decroo, Tom, et al.
Publicado: (2017)

Tackling challenges of TB/MDRTB in China: concerted actions are imperative
por: Tang, Shenglan
Publicado: (2015)

The multi-step process of building TB/HIV collaboration in Cambodia
por: Eang, Mao Tan, et al.
Publicado: (2012)

Access to and affordability of healthcare for TB patients in China: issues and challenges
por: Tang, Shenglan, et al.
Publicado: (2016)

Horizon scanning: what next for bovine TB control in England?
por: McCormack, James
Publicado: (2023)

World TB day: a new opportunity to reimagine workplace health
por: Reid, Michael, et al.
Publicado: (2021)

TB or NTM: Can a new multiplex PCR assay be the answer?
por: Anand, Appakkudal R, et al.
Publicado: (2021)

Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients
por: Muefong, Caleb Nwongbouwoh, et al.
Publicado: (2021)

Identification of Probable Early-Onset Biomarkers for Tuberculosis Disease Progression
por: Sutherland, Jayne S., et al.
Publicado: (2011)

Development of chronic lung impairment in Mozambican TB patients and associated risks
por: Khosa, Celso, et al.
Publicado: (2020)

Biomarkers for early diagnosis of diabetic kidney disease: still a long way to go
por: Kumar, Vivek, et al.
Publicado: (2022)

New Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Yoshida, Katsunori
Publicado: (2015)

Diagnostic Opportunities for Optimizing Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania
por: Mpagama, Stellah G
Publicado: (2018)

Phosphatidylcholine Metabolic Transformation and Progression Signature as a Pharmacodynamic Biomarker
por: Aboagye, Eric O.
Publicado: (2010)

Predictive biomarkers for cognitive decline during progressive HIV infection
por: Gendelman, Howard E.
Publicado: (2019)

Yoga for Control of Progression in the Early Stage of NCDs
por: Nadholta, Pooja, et al.
Publicado: (2023)

The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals
por: Lönnroth, Knut, et al.
Publicado: (2016)

Fighting TB stigma: we need to apply lessons learnt from HIV activism
por: Daftary, Amrita, et al.
Publicado: (2017)

TB research requires strong protections, innovation, and increased funding in response to COVID-19
por: Nyang’wa, B. T., et al.
Publicado: (2021)

Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status
por: Sitoe, Nádia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7pf2ruvbi0cek6p6kmlimn75p